Antibiotic use in children hospitalised for influenza, 2010-2021 : the Canadian Immunization Monitoring Program Active (IMPACT)
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany..
PURPOSE: To determine characteristics associated with inappropriate antibiotic use amongst children hospitalised for influenza.
METHODS: We performed active surveillance for laboratory-confirmed influenza hospitalizations amongst children ≤ 16 years old at the 12 Canadian Immunization Monitoring Program Active hospitals, from September 2010 to August 2021. Antibiotic use was presumed appropriate if any of the following indications were met: age < 1 month, immunocompromised, hemoglobinopathy, laboratory-confirmed bacterial infection, radiographically confirmed pneumonia, admission to an intensive care unit and mechanical ventilation. Regression analyses were used to identify baseline and clinical characteristics associated with antibiotic use amongst patients without an appropriate indication.
RESULTS: Amongst 8971 children, 6424 (71.6%) received any antibiotics during their hospitalisation. Amongst the 4429 children without an appropriate indication, 2366 (53.2%) received antibiotics. Antibiotic use amongst children without appropriate indication differed between study centres, ranging from 33.2% to 66.1% (interquartile range [IQR] 50.6-56.3%); it did not change significantly over time (p-value for trend = 0.28). In multivariable analyses, older age (adjusted odds ratio [aOR] 0.97, 95% confidence interval [CI] 0.96-0.99), presence of any high-risk condition (aOR 0.80, 95% CI 0.70-0.92), influenza virus type B (aOR 0.8, 95% CI 0.70-0.91) and croup (aOR 0.64, 95% CI 0.49-0.83) were associated with less, whilst fever ≥ 38.5 °C (aOR 1.82, 95% CI 1.42-2.35) and hospitalisation duration (aOR 1.12, 95% CI 1.09-1.15) were associated with more inappropriate antibiotic use.
CONCLUSIONS: Over two-third of children hospitalised for influenza received antibiotics, including over half of those without an appropriate indication for antibiotic treatment. Differences amongst study centres suggest the importance of contextual determinants of antibiotic use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Infection - (2023) vom: 06. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schober, Tilmann [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibiotic stewardship |
|---|
| Anmerkungen: |
Date Revised 06.11.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1007/s15010-023-02124-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364224592 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364224592 | ||
| 003 | DE-627 | ||
| 005 | 20231226095008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-023-02124-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1214.xml |
| 035 | |a (DE-627)NLM364224592 | ||
| 035 | |a (NLM)37930625 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schober, Tilmann |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antibiotic use in children hospitalised for influenza, 2010-2021 |b the Canadian Immunization Monitoring Program Active (IMPACT) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. | ||
| 520 | |a PURPOSE: To determine characteristics associated with inappropriate antibiotic use amongst children hospitalised for influenza | ||
| 520 | |a METHODS: We performed active surveillance for laboratory-confirmed influenza hospitalizations amongst children ≤ 16 years old at the 12 Canadian Immunization Monitoring Program Active hospitals, from September 2010 to August 2021. Antibiotic use was presumed appropriate if any of the following indications were met: age < 1 month, immunocompromised, hemoglobinopathy, laboratory-confirmed bacterial infection, radiographically confirmed pneumonia, admission to an intensive care unit and mechanical ventilation. Regression analyses were used to identify baseline and clinical characteristics associated with antibiotic use amongst patients without an appropriate indication | ||
| 520 | |a RESULTS: Amongst 8971 children, 6424 (71.6%) received any antibiotics during their hospitalisation. Amongst the 4429 children without an appropriate indication, 2366 (53.2%) received antibiotics. Antibiotic use amongst children without appropriate indication differed between study centres, ranging from 33.2% to 66.1% (interquartile range [IQR] 50.6-56.3%); it did not change significantly over time (p-value for trend = 0.28). In multivariable analyses, older age (adjusted odds ratio [aOR] 0.97, 95% confidence interval [CI] 0.96-0.99), presence of any high-risk condition (aOR 0.80, 95% CI 0.70-0.92), influenza virus type B (aOR 0.8, 95% CI 0.70-0.91) and croup (aOR 0.64, 95% CI 0.49-0.83) were associated with less, whilst fever ≥ 38.5 °C (aOR 1.82, 95% CI 1.42-2.35) and hospitalisation duration (aOR 1.12, 95% CI 1.09-1.15) were associated with more inappropriate antibiotic use | ||
| 520 | |a CONCLUSIONS: Over two-third of children hospitalised for influenza received antibiotics, including over half of those without an appropriate indication for antibiotic treatment. Differences amongst study centres suggest the importance of contextual determinants of antibiotic use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antibiotic stewardship | |
| 650 | 4 | |a Antibiotics | |
| 650 | 4 | |a Children | |
| 650 | 4 | |a Hospitalisation | |
| 650 | 4 | |a Influenza | |
| 700 | 1 | |a Morris, Shaun K |e verfasserin |4 aut | |
| 700 | 1 | |a Bettinger, Julie A |e verfasserin |4 aut | |
| 700 | 1 | |a Burton, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Halperin, Scott A |e verfasserin |4 aut | |
| 700 | 1 | |a Jadavji, Taj |e verfasserin |4 aut | |
| 700 | 1 | |a Kazmi, Kescha |e verfasserin |4 aut | |
| 700 | 1 | |a Modler, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Sadarangani, Manish |e verfasserin |4 aut | |
| 700 | 1 | |a Papenburg, Jesse |e verfasserin |4 aut | |
| 700 | 0 | |a Canadian Immunization Monitoring Program Active (IMPACT) Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Foo, Cheryl |e investigator |4 oth | |
| 700 | 1 | |a Bridger, Natalie |e investigator |4 oth | |
| 700 | 1 | |a Top, Karina |e investigator |4 oth | |
| 700 | 1 | |a Thibeault, Roseline |e investigator |4 oth | |
| 700 | 1 | |a Lebel, Marc |e investigator |4 oth | |
| 700 | 1 | |a Le Saux, Nicole |e investigator |4 oth | |
| 700 | 1 | |a Bullard, Jared |e investigator |4 oth | |
| 700 | 1 | |a Purewal, Rupeena |e investigator |4 oth | |
| 700 | 1 | |a Sauvé, Laura |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d 1973 |g (2023) vom: 06. Nov. |w (DE-627)NLM00001740X |x 1439-0973 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:06 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15010-023-02124-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 06 |c 11 | ||